Market Wire - New Study Suggests Cymbalta(R) Reduced Depression Symptoms at Least as Fast as a Leading Competitor
Wednesday, December 31st, 2008 Cymbalta (duloxetine hydrochloride)
reduced symptoms of depression at least as fast as Lexapro
(escitalopram) by the end of two weeks, according to results from the first
head-to-head study comparing the two antidepressants. The results were
released by Eli Lilly and Company (NYSE: LLY) at a meeting of a major
scientific society.
In this eight-week study, Cymbalta, a serotonin and norepinephrine reuptake
i…
